Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

PML-IRIS during Fingolimod Diagnosed after Natalizumab Discontinuation.
CD8+ T-Cell Deficiency, Epstein-Barr Virus Infection, Vitamin D Deficiency, and Steps to Autoimmunity: A Unifying Hypothesis.
FDA Approves First Drug for Lou Gehrig's Disease
Reversible cerebral vasoconstriction syndrome associated with fingolimod treatment in relapsing-remitting multiple sclerosis three months after childbirth.
Pharmacodynamics, pharmacokinetics, and safety of multiple doses of FTY720 in stable renal transplant patients: a multicenter, randomized, placebo-controlled, phase I study.
FTY720, sphingosine 1-phosphate receptor modulator, selectively radioprotects hippocampal neural stem cells.
Retinal Axonal Loss Begins Early in the Course of Multiple Sclerosis and Is Similar between Progressive Phenotypes.
Characteristics of persons with overactive bladder of presumed neurologic origin: Results from the boston area community health (BACH) survey.
Please mind the gap: axonal transport deficits in multiple sclerosis neurodegeneration.
Enhanced Axonal Metabolism during Early Natalizumab Treatment in Relapsing-Remitting Multiple Sclerosis.
Post-natalizumab clinical and radiological findings in a cohort of multiple sclerosis patients: 12-month follow-up.
[Biosimilar of interferon-beta 1b in the treatment of multiple sclerosis and the own experience in the use of ronbetal.]
Role of Proangiogenic Factors in Immunopathogenesis of Multiple Sclerosis.
Microglia: Architects of the Developing Nervous System.
Rationale and design of a clinical trial investigating resistance training as an aid to smoking cessation in persons with multiple sclerosis.
Urinary JCV-DNA Testing during Natalizumab Treatment May Increase Accuracy of PML Risk Stratification.
IL-1 signal affects both protection and pathogenesis of virus-induced chronic CNS demyelinating disease.
Hypothyroidism in multiple sclerosis patient during fingolimod treatment.
Efficacy and safety of alemtuzumab in patients with relapsing-remitting multiple sclerosis who relapsed on prior therapy: Four-year follow-up of the Care-MS II study.
Center for Drug Evaluation and Research Approval Letter, application number: 21-897
The genetic and environmental bases of complex human-disease: extending the utility of twin-studies.
The Impact of Social Media on Dissemination and Implementation of Clinical Practice Guidelines: A Longitudinal Observational Study.
Multiple sclerosis: Cognitive status declines on warmer days in patients with multiple sclerosis.
Gammaherpesvirus Latency Accentuates EAE Pathogenesis: Relevance to Epstein-Barr Virus and Multiple Sclerosis.
Low-contrast multifocal visual evoked potentials: Identifying more shades of gray in MS.

Pages